OBJECTIVE: Gestational diabetes mellitus (GDM) is thought to modify the pattern of placental transcriptome. In a microarray study and a confirmatory quantitative real-time reverse transcription-polymerase chain reaction study, we investigated global placental gene expression in GDM. STUDY DESIGN: Ribonucleic acid was extracted from placental samples collected from 19 GDM cases and 21 controls. Oligonucleotide probes representing 22,000 genes were used to measure gene expression. Differential gene expression was evaluated using the Student t test, fold change assessment, and significance analysis of microarrays. Path analysis was used to assess functions and functional relationships of differentially expressed genes. RESULTS: Sixty-six genes participating in cell functions involving cell activation, immune response, organ development, and regulation of cell death were differentially expressed in GDM placentas. These genes include previously described candidate genes (eg, LEP, CEBPA, and MIF), genes with related functions (eg, ADFP), and novel genes (eg, AQP3). CONCLUSION: Expression of genes responsible for diverse biologic processes are modified in GDM.
OBJECTIVE:Gestational diabetes mellitus (GDM) is thought to modify the pattern of placental transcriptome. In a microarray study and a confirmatory quantitative real-time reverse transcription-polymerase chain reaction study, we investigated global placental gene expression in GDM. STUDY DESIGN: Ribonucleic acid was extracted from placental samples collected from 19 GDM cases and 21 controls. Oligonucleotide probes representing 22,000 genes were used to measure gene expression. Differential gene expression was evaluated using the Student t test, fold change assessment, and significance analysis of microarrays. Path analysis was used to assess functions and functional relationships of differentially expressed genes. RESULTS: Sixty-six genes participating in cell functions involving cell activation, immune response, organ development, and regulation of cell death were differentially expressed in GDM placentas. These genes include previously described candidate genes (eg, LEP, CEBPA, and MIF), genes with related functions (eg, ADFP), and novel genes (eg, AQP3). CONCLUSION: Expression of genes responsible for diverse biologic processes are modified in GDM.
Authors: Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher Journal: J Matern Fetal Neonatal Med Date: 2010-05-26
Authors: L Schober; D Radnai; J Spratte; A Kisielewicz; E Schmitt; K Mahnke; H Fluhr; L Uhlmann; C Sohn; A Steinborn Journal: Clin Exp Immunol Date: 2014-07 Impact factor: 4.330
Authors: J M Salbaum; C Kruger; X Zhang; N Arbour Delahaye; G Pavlinkova; D H Burk; C Kappen Journal: Diabetologia Date: 2011-04-14 Impact factor: 10.122
Authors: Thomas R Magee; Michael G Ross; Lauren Wedekind; Mina Desai; Siri Kjos; Louiza Belkacemi Journal: J Diabetes Complications Date: 2014-03-24 Impact factor: 2.852
Authors: Paranthaman SenthamaraiKannan; Maureen A Sartor; Kyle T O'Connor; Jonathan C Neumann; James P Klyza; Paul A Succop; Brad D Wagner; Saikumar Karyala; Mario Medvedovic; Anil G Menon Journal: Physiol Genomics Date: 2011-01-04 Impact factor: 3.107
Authors: Daniel A Enquobahrie; Michelle A Williams; Chunfang Qiu; David S Siscovick; Tanya K Sorensen Journal: J Matern Fetal Neonatal Med Date: 2011-01-10
Authors: Tibor Várkonyi; Levente Lázár; Attila Molvarec; Nándor Gábor Than; János Rigó; Bálint Nagy Journal: BMC Med Genet Date: 2010-02-11 Impact factor: 2.103